Comments

Phio Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Phio Pharma (PHIO) operate in?

Phio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PHIONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.34

0.043.08%

Pre-Market: Mar 7, 6:53 PM EDT

Phio Pharma (PHIO) Forecast

News Earnings Phio Pharma (PHIO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Phio Pharma Stock Price, Quotes and Forecasts | NASDAQ:PHIO | Benzinga

Explore Phio Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHIO.

Open	-
Close	-
Volume / Avg.	0 / 6.48M
Day Range	- - -
52 Wk Range	1.22 - 9.99
Market Cap	$6.40M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	0.95%
Days to Cover	1

Recent News

Dow Gains Over 200 Points; Signet Jewelers Shares Plunge

Avi Kapoor

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Avi Kapoor

What's Going On With Phio Pharmaceuticals Stock Today?

Phio Pharmaceuticals stock drops 39.1% after announcing a $3.19 million direct offering and concurrent private placement.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 6.48M
Day Range	- - -
52 Wk Range	1.22 - 9.99
Market Cap	$6.40M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	0.95%
Days to Cover	1

About Phio Pharmaceuticals Corp

Sector

Health Care

Industry

Biotechnology

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Phio Pharma (PHIO) stock?

You can purchase shares of Phio Pharma (NASDAQ:PHIO) through any online brokerage.

View our list of the best stock brokerages

Who are Phio Pharma (PHIO) competitors?

Other companies in Phio Pharma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Portage Biotech (NASDAQ:PRTG).

What is the forecast, or price target, for Phio Pharma (PHIO) stock?

Phio Pharma has a consensus price target of $4.00.

What is the current price for Phio Pharma (PHIO)?

The stock price for Phio Pharma (NASDAQ: PHIO) is $1.34 last updated March 7, 2025 at 6:53 PM EST.

Does Phio Pharma (PHIO) pay a dividend?

There are no upcoming dividends for Phio Pharma.

When is Phio Pharma (NASDAQ:PHIO) reporting earnings?

Phio Pharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Phio Pharma (PHIO) going to split?

There is no upcoming split for Phio Pharma.

What sector and industry does Phio Pharma (PHIO) operate in?

Phio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.